Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatropin - Dong-A

Next Previous
Drug Profile

Somatropin - Dong-A

Alternative Names: DA-3002; Growtropin; Growtropin II; Growtropin-AQ; hGH-Dong-A; Human growth hormone-Dong-A

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A ST
  • Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
  • Mechanism of Action Human growth hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature

Most Recent Events

  • 23 Mar 2019 Efficacy and adverse event data from a phase III trial in Short stature (In children, associated with Turner syndrome) presented at the 101st Annual Meeting of the Endocrine Society (ENDO,
  • 01 Feb 2016 Dong-A Pharmaceutical initiates a phase III trial for Short stature (In children, In adolescents; associated with small for gestational age at birth) in South Korea (Parenteral, Injection) (NCT02770157)
  • 28 Feb 2013 Dong-A Pharmaceutical initiates enrolment in a phase III trial for Short stature in children (associated with Turner's syndrome) in South Korea (NCT01813630)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top